Investigational Site Number : 380004

Florence 50134

1 studies enrolling now · 3 studies all time

What they study most

Fabry Disease, Hematopoietic Neoplasm

Studies at this site

• Fabry Disease Registry & Pregnancy Sub-registry — Recruiting now
• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed